Cargando…

CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation

Migration of encephalitogenic CD4(+) T lymphocytes across the blood-brain barrier is an essential step in the pathogenesis of multiple sclerosis (MS). We here demonstrate that expression of the co-stimulatory receptor NKG2D defines a subpopulation of CD4(+) T cells with elevated levels of markers fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruck, Tobias, Bittner, Stefan, Gross, Catharina C., Breuer, Johanna, Albrecht, Stefanie, Korr, Sabrina, Göbel, Kerstin, Pankratz, Susann, Henschel, Christian M., Schwab, Nicholas, Staszewski, Ori, Prinz, Marco, Kuhlmann, Tanja, Meuth, Sven G., Wiendl, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839937/ https://www.ncbi.nlm.nih.gov/pubmed/24282598 http://dx.doi.org/10.1371/journal.pone.0081455

Ejemplares similares

Correction: CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation
por: Ruck, Tobias, et al.
Publicado: (2013)

The NKG2D – IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies
por: Ruck, Tobias, et al.
Publicado: (2015)

Long-term efficacy of alemtuzumab in polymyositis
por: Ruck, Tobias, et al.
Publicado: (2015)

CD4(+ )CD25(+ )FoxP3(+ )regulatory T cells suppress cytotoxicity of CD8(+ )effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level
por: Göbel, Kerstin, et al.
Publicado: (2012)

Murine K(2P)5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K(2P)3.1- and K(V)1.3-Dependent Mechanisms
por: Bittner, Stefan, et al.
Publicado: (2015)

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
por: Ruck, Tobias, et al.
Publicado: (2015)

Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells
por: Göbel, Kerstin, et al.
Publicado: (2016)

The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders
por: Pankratz, Susann, et al.
Publicado: (2016)

T(H) Cells and Cytokines in Encephalitogenic Disorders
por: Krishnarajah, Sinduya, et al.
Publicado: (2022)

An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Function
por: Kleffner, Ilka, et al.
Publicado: (2017)

The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders—A Systematic Review
por: Göbel, Kerstin, et al.
Publicado: (2018)

Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response
por: Bierhansl, Laura, et al.
Publicado: (2019)

Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
por: Schwab, Nicholas, et al.
Publicado: (2016)

Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
por: Yong, W. K., et al.
Publicado: (1982)

Evans syndrome associated with sterile inflammation of the central nervous system: a case report
por: Simon, Ole Jan, et al.
Publicado: (2013)

ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential
por: Ruck, Tobias, et al.
Publicado: (2016)

Encephalitogenicity of myelin basic protein exon-2 peptide in mice
por: Fritz, Robert B., et al.
Publicado: (1994)

Blood-brain barrier modeling: challenges and perspectives
por: Ruck, Tobias, et al.
Publicado: (2015)

Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
por: David, Christina, et al.
Publicado: (2023)

Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation
por: Veremeyko, Tatyana, et al.
Publicado: (2018)

Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis
por: Pfeuffer, Steffen, et al.
Publicado: (2021)

Effects of encephalitogenic factor on lymphocytic electrophoretic mobility for cancer patients and controls.
por: Chiu, B., et al.
Publicado: (1977)

T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
por: Yang, Yuhong, et al.
Publicado: (2009)

TCR Affinity for Self-Ligands Influences the Development and Function of Encephalitogenic T Cells
por: Li, Jianwei, et al.
Publicado: (2011)

IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity
por: Lee, Priscilla W., et al.
Publicado: (2018)

c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
por: Benkhoucha, Mahdia, et al.
Publicado: (2020)

GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
por: Krieg, Paula F., et al.
Publicado: (2023)

Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8(+) T cell attack in the CNS gray matter
por: Melzer, Nico, et al.
Publicado: (2013)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2022)

Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
por: Möhn, Nora, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG(35-55)) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
por: Bittner, Stefan, et al.
Publicado: (2014)

CONTRIBUTIONS TO THE PATHOLOGY OF EXPERIMENTAL VIRUS ENCEPHALITIS : II. HERPETIC STRAINS OF ENCEPHALITOGENIC VIRUS.
por: Flexner, Simon, et al.
Publicado: (1925)

CONTRIBUTIONS TO THE PATHOLOGY OF EXPERIMENTAL VIRUS ENCEPHALITIS : I. AN EXOTIC STRAIN OF ENCEPHALITOGENIC VIRUS.
por: Flexner, Simon, et al.
Publicado: (1925)

The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
por: Segal, Benjamin M.
Publicado: (2019)

Neurons promote encephalitogenic CD4(+) lymphocyte infiltration in experimental autoimmune encephalomyelitis
por: Nakazato, Yuki, et al.
Publicado: (2020)

Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells
por: Schroeter, Christina B., et al.
Publicado: (2021)

Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis
por: Vogelsang, Anna, et al.
Publicado: (2021)

Ocrelizumab initiation in patients with MS: A multicenter observational study
por: Ellwardt, Erik, et al.
Publicado: (2020)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory Conditions
por: Gross, Catharina C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_28c223691rrcpf0nv6bp4m888l